Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Friday Frontline: June 14, 2019

June 14th 2019, 5:43pm

Article

From the 9/11 Victim Compensation Fund to the untimely passing of an inspirational Olympic runner, here’s what is making headlines in the cancer space this week.

Tireless Ability to Care

May 26th 2019, 4:00pm

Article

Amy Setesak, B.S.N., RN, CMSRN from Memorial Sloan Kettering Cancer Center, New York, was nominated by her colleague, Aly Fox, B.S.N., RN, CMSRN, for CURE®’s Extraordinary Healer® Award.

Surviving Glioblastoma: I am the Four Percent

May 23rd 2019, 9:36pm

Article

Four out of 100. That is the survival rate for stage 4 glioblastoma: four percent.

Actions with Brain Tumor Awareness Month in May and Beyond

May 23rd 2019, 8:56pm

Article

Learn about awareness and actions strategies during Brain Tumor Awareness Month and beyond.

Friday Frontline: May 17, 2019

May 17th 2019, 9:25pm

Article

From the first annual Glioblastoma Awareness Day to politics and today’s top performers, here’s what’s making headlines in the cancer space this week.​

Carrying the Weight of Chronic Illness

May 14th 2019, 11:22pm

Article

Carrying chronic illness can be very difficult, but there are ways to navigate the world without being crushed by the weight of what we cannot control.

Severe Hearing Loss from Pediatric Brain Tumor Treatment May Cause Cognitive Difficulties

May 13th 2019, 10:57pm

Article

Children diagnosed with embryonal brain tumors who have experienced treatment-related hearing loss exhibited greater difficulties reading – in particular, with phonological skills and processing speed, according to study results.

Friday Frontline: May 10, 2019

May 10th 2019, 6:45pm

Article

From National Women's Health Week to today’s top athletes, here’s what’s making headlines in the cancer space this week.

Opdivo Plus Radiation Fails to Prolong Survival in Subtype of Glioblastoma

May 9th 2019, 7:24pm

Article

The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.

Friday Frontline: April 26, 2019

April 26th 2019, 9:37pm

Article

From a sweet fundraiser for breast cancer to today’s top performers and athletes, here’s what’s making headlines in the cancer space this week.